Literature DB >> 7995401

Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range.

P W Barry1, C O'Callaghan.   

Abstract

We wanted to determine the amount of salbutamol available in respirable particles from the Volumatic spacer device after one, two or five actuations of a metered-dose inhaler into the spacer prior to analysis. A glass multistage liquid impinger was used to determine particle size. Aerosol was sampled after one, two or five actuations from a metered-dose inhaler into a Volumatic spacer. Each experiment was repeated four times. The amount of salbutamol recovered per actuation in particles less than 5 microns (mean and 95% confidence intervals) was: 54.3 micrograms (48.3-60.1) after one actuation; 42.4 micrograms (38.2-46.5) after two actuations, and 20.7 micrograms (17.5-23.9) after five actuations. We conclude that multiple actuations of salbutamol into the Volumatic spacer do not linearly increase the amount of drug available for inhalation. To maximize drug delivery, single actuations should be used prior to inhalation. In comparative studies of drugs and dosages, it must be remembered that the amount of drug delivered is not the same as that administered.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995401     DOI: 10.1183/09031936.94.07091707

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device.

Authors:  D J Clark; B J Lipworth
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

2.  Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants.

Authors:  J H Wildhaber; S G Devadason; E Eber; M J Hayden; M L Everard; Q A Summers; P N LeSouëf
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

3.  Emergency treatment of asthma.

Authors:  P W Barry; C O'Callaghan
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

4.  Factors affecting total and "respirable" dose delivered by a salbutamol metered dose inhaler.

Authors:  M L Everard; S G Devadason; Q A Summers; P N Le Souëf
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

Review 5.  Use of inhaler devices in pediatric asthma.

Authors:  Fernando Maria De Benedictis; David Selvaggio
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.

Authors:  Roberta Pisi; Marina Aiello; Andrea Zanini; Panagiota Tzani; Davide Paleari; Emilio Marangio; Antonio Spanevello; Gabriele Nicolini; Alfredo Chetta
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-19

Review 7.  Optimal administration of bronchodilators with valved holding chambers in preschool children: a review of literature.

Authors:  Péter Csonka; Terhi Tapiainen; Mika J Mäkelä; Lauri Lehtimäki
Journal:  Eur J Pediatr       Date:  2021-04-20       Impact factor: 3.183

8.  Outpatient management of asthma in children.

Authors:  André Schultz; Andrew C Martin
Journal:  Clin Med Insights Pediatr       Date:  2013-04-14

9.  The challenge of delivering therapeutic aerosols to asthma patients.

Authors:  Federico Lavorini
Journal:  ISRN Allergy       Date:  2013-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.